Withdrawn trial tested new drug to control rare kidney stone disease
NCT ID NCT04147871
Summary
This study aimed to test different doses of an experimental drug called ADV7103 for people with cystinuria, a rare condition that causes painful kidney stones. The goal was to see if the drug could safely and effectively raise urine pH to help prevent stone formation. The trial was designed for patients from 6 months to 70 years old but was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Lille
Lille, Lille, 59000, France
-
CHU Grenoble
Grenoble, Grenoble Cedex, 38043, France
-
CHU Pitié-Salpétrière
Paris, Paris, 15013, France
-
CHU Purpan
Toulouse, Toulouse Cedex 9, 31059, France
-
CHU Reims
Reims, Reims, 51100, France
-
Centre Hospitalier Universitaire de Lyon - Hôpital Femme Mère Enfant
Bron, 69500, France
-
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
-
Hôpital Américain CHU de Reims
Reims, Reims, 51092, France
-
Hôpital Necker AP-HP
Paris, Paris, 75015, France
-
Hôpital Necker Enfants Malades
Paris, Paris, 75015, France
-
Hôpital Ténon - Explorations fonctionnelles Mutlidisciplinaires et INSERM UMR S 1155
Paris, Paris, 75020, France
-
UZ Leuven, Gasthuisberg Hospital
Leuven, Leuven, Belgium
Conditions
Explore the condition pages connected to this study.